IHC analysis reveals that GPIIb/IIIa is significantly reduced on thrombus tissue in the DVT and PDI inhibitor group and the DVT and GRP94 inhibitor group as compared to the DVT group (both p < 0.01, Figure 3A,B). This evidence concerns the gene ITGA2B and deep vein thrombosis.